COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome

This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramaswamy, Swathi Beladakere, Govindarajan, Raghav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369032/
https://www.ncbi.nlm.nih.gov/pubmed/32508329
http://dx.doi.org/10.3233/JND-200520
Descripción
Sumario:This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or crisis, no COVID-19 related complications), with no changes to her immunosuppressive therapy. Treatment of MG patients with COVID-19 needs to be tailored to individual patient.

Ejemplares similares